Pacira Biosciences Inc
NASDAQ:PCRX

Watchlist Manager
Pacira Biosciences Inc Logo
Pacira Biosciences Inc
NASDAQ:PCRX
Watchlist
Price: 25.84 USD -0.35% Market Closed
Market Cap: 1.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

PCRX Price Targets Summary
Pacira Biosciences Inc

Wall Street analysts forecast PCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCRX is 39.78 USD with a low forecast of 26.26 USD and a high forecast of 68.25 USD.

PCRX Lowest Forecast
Wall Street Target
26.26 USD
2% Upside
PCRX Average Forecast
Wall Street Target
39.78 USD
54% Upside
PCRX Highest Forecast
Wall Street Target
68.25 USD
164% Upside
Lowest
Price Target
26.26 USD
2% Upside
Average
Price Target
39.78 USD
54% Upside
Highest
Price Target
68.25 USD
164% Upside
Pacira Biosciences Inc Competitors:
Price Targets
326030
SK Biopharmaceuticals Co Ltd
54% Upside
A
AQST
Aquestive Therapeutics Inc
270% Upside
AXSM
Axsome Therapeutics Inc
72% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
7% Downside
326030
SK Biopharmaceuticals Co Ltd
54% Upside
A
AQST
Aquestive Therapeutics Inc
270% Upside
AXSM
Axsome Therapeutics Inc
72% Upside
C
300765
CSPC Innovation Pharmaceutical Co Ltd
7% Downside
C
CONCORDBIO
Concord Biotech Ltd
9% Upside
4569
Kyorin Holdings Inc
1% Upside

Revenue
Forecast

Revenue Estimate
Pacira Biosciences Inc

For the last 8 years the compound annual growth rate for Pacira Biosciences Inc's revenue is 12%. The projected CAGR for the next 3 years is 10%.

12%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pacira Biosciences Inc

The compound annual growth rate of Pacira Biosciences Inc's operating income for the next 3 years is 45%.

N/A
Past Growth
45%
Estimated Growth
Estimates Accuracy
-52%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pacira Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-68%
Average Miss
What are analyst estimates?

See Also

Summary
PCRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
PCRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PCRX stock valuation using valuation multiples.
Wall Street Estimates
PCRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PCRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCRX's stock price target?
Price Target
39.78 USD

According to Wall Street analysts, the average 1-year price target for PCRX is 39.78 USD with a low forecast of 26.26 USD and a high forecast of 68.25 USD.

What is Pacira Biosciences Inc's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Pacira Biosciences Inc's revenue is 12%. The projected CAGR for the next 3 years is 10%.

What is Pacira Biosciences Inc's Operating Income forecast?
Projected CAGR
45%

The compound annual growth rate of Pacira Biosciences Inc's operating income for the next 3 years is 45%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 258,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.